Diamondbacks general manager Dave Stewart said Sunday that he continues to monitor the potential availability of Japanese hurler Kenta Maeda.
It's anticipated that the 27-year-old right-hander will be posted by the Hiroshima Carp this winter. The Diamondbacks appear to be exploring all possible options as they look to add a front-line starter to their rotation before the 2016 season begins.
Diamondbacks general manager Dave Stewart told Nick Piecoro of the Arizona Republic that Johnny Cueto rejected an offer that the club made to him earlier this month.
The club remains interested in the free agent right-hander, who is likely waiting to see how the market plays out for the top pitchers (David Price and Zack Greinke) before he signs. By all accounts, the Tigers inking Jordan Zimmermann to a five-year, $110 million contract on Sunday could actually hurt the market for Cueto, who is also seeking more than $20 million annually.
Jon Heyman of CBS Sports reports that the Blue Jays have narrowed their search for a general manager to two finalists, interim general manager Tony LaCava and Ross Atkins.
Atkins is an executive in the Indians organization and worked with new team president Mark Shapiro for 15 years together in Cleveland. Shapiro has stated that he would like to have his new general manager in place before the Winter Meetings begin on December 7, so expect a resolution to occur this week.
According to Jerry Crasnick of ESPN, the Blue Jays have expressed interest in free agent reliever Ryan Madson.
Crasnick reports that the Jays are in the market to upgrade their bullpen and prefer relievers with prior closing experience. The 35-year-old right-hander certainly fits that bill, having 55 career saves under his belt, 32 of them as the Phillies stopper in 2011.
FOX Sports' Ken Rosenthal reports that Ben Zobrist is the Mets' "No. 1 target" this offseason.
It's not surprising, as they've been connected to him since early on in the offseason. Rosenthal notes that the Nationals, Braves and Giants, among other clubs, are also in on Zobrist. The reports adds that the market for Zobrist is "likely to become more defined in next few days" and "willingness to guarantee a fourth year likely will be a deciding factor." Zobrist turns 35 next May, so giving him a four-year deal would be awfully risky.